CW Advisors LLC Grows Stake in Cardinal Health, Inc. $CAH

CW Advisors LLC increased its stake in shares of Cardinal Health, Inc. (NYSE:CAH) by 130.6% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 18,656 shares of the company’s stock after purchasing an additional 10,565 shares during the period. CW Advisors LLC’s holdings in Cardinal Health were worth $3,134,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors also recently bought and sold shares of CAH. Counterpoint Mutual Funds LLC acquired a new position in Cardinal Health during the second quarter worth about $1,911,000. Atlantic Union Bankshares Corp purchased a new position in Cardinal Health in the 2nd quarter worth approximately $79,000. KLP Kapitalforvaltning AS boosted its holdings in shares of Cardinal Health by 4.0% during the 2nd quarter. KLP Kapitalforvaltning AS now owns 114,198 shares of the company’s stock worth $19,185,000 after purchasing an additional 4,400 shares during the last quarter. Acadian Asset Management LLC grew its position in shares of Cardinal Health by 92.5% in the second quarter. Acadian Asset Management LLC now owns 1,679,176 shares of the company’s stock valued at $282,063,000 after purchasing an additional 807,063 shares in the last quarter. Finally, Czech National Bank increased its holdings in shares of Cardinal Health by 5.1% in the second quarter. Czech National Bank now owns 58,341 shares of the company’s stock valued at $9,801,000 after purchasing an additional 2,857 shares during the last quarter. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Cardinal Health Price Performance

NYSE CAH opened at $198.93 on Friday. The stock has a market capitalization of $47.27 billion, a P/E ratio of 30.00, a PEG ratio of 1.45 and a beta of 0.63. The firm’s 50-day moving average is $182.59 and its two-hundred day moving average is $165.13. Cardinal Health, Inc. has a 12 month low of $114.60 and a 12 month high of $214.93.

Cardinal Health (NYSE:CAH) last released its quarterly earnings results on Thursday, October 30th. The company reported $2.55 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.22 by $0.33. Cardinal Health had a net margin of 0.68% and a negative return on equity of 84.37%. The business had revenue of $64.01 billion for the quarter, compared to the consensus estimate of $59.41 billion. During the same period in the previous year, the firm earned $1.88 EPS. The business’s revenue was up 22.4% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. As a group, analysts anticipate that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, January 15th. Stockholders of record on Friday, January 2nd will be given a dividend of $0.5107 per share. This represents a $2.04 annualized dividend and a dividend yield of 1.0%. The ex-dividend date is Friday, January 2nd. Cardinal Health’s dividend payout ratio (DPR) is currently 30.77%.

Analyst Ratings Changes

CAH has been the topic of a number of recent research reports. Robert W. Baird set a $232.00 price objective on Cardinal Health in a research note on Friday, October 31st. Weiss Ratings reissued a “buy (b)” rating on shares of Cardinal Health in a research report on Wednesday, October 8th. UBS Group raised their price objective on shares of Cardinal Health from $185.00 to $220.00 and gave the stock a “buy” rating in a research report on Friday, October 31st. TD Cowen boosted their target price on shares of Cardinal Health from $183.00 to $225.00 and gave the company a “buy” rating in a report on Monday, November 3rd. Finally, Leerink Partners increased their price target on shares of Cardinal Health from $211.00 to $230.00 and gave the company an “outperform” rating in a research note on Monday, November 17th. Twelve research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, Cardinal Health presently has an average rating of “Moderate Buy” and a consensus price target of $206.57.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.